CVS HEALTH Corp
In its 13F for Q3 2025 (holdings as of September 30, 2025, filed October 31, 2025), CVS HEALTH Corp reported 3 stock positions worth $102.9 million. Its top holding was SS SPDR S&P 500 ETF Trust-US (SPY) at 99.6% of the portfolio, followed by Prudential Financial (PRU, 0.3%) and Health Catalyst (HCAT, 0.1%). Compared with Q2 2025, it reduced 1. The biggest sale was SS SPDR S&P 500 ETF Trust-US (SPY, shares −50%).
- Most Recent 13F
- Q2 2026
- Location
- WOONSOCKET, RI
- CIK
- 0000064803
- Portfolio Value
- $102.9M (Q3 2025)
- SEC Filing
- 0001193125-25-260806 ↗ filed Oct 31, 2025
Holdings Value
Holdings 3 stocks · $102.9M
Portfolio Sells Q2 2025 → Q3 2025
| SPY SS SPDR S&P 500 ETF Trust-US | Reduce -50.0% | 99.64% | −0.14 |
Portfolio Buys Q2 2025 → Q3 2025
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 21 | $225.2M | IGSB, IGIB, IEI, SHY, USHY |
| Q1 2026 | 33 | $212.3M | SPY, IEI, SHY, IGSB, AGG |
| Q4 2025 | 9 | $135.3M | SPY, USHY, IGIB, JAAA, IGSB |
| Q3 2025 | 3 | $102.9M | SPY, PRU, HCAT |
| Q2 2025 | 3 | $190.6M | SPY, PRU, HCAT |
| Q1 2025 | 3 | $172.7M | SPY, PRU, HCAT |
| Q4 2024 | 3 | $233.7M | SPY, PRU, HCAT |
| Q3 2024 | 5 | $230.2M | SPY, VYM, HDV, PRU, HCAT |
| Q2 2024 | 5 | $216.8M | SPY, VYM, HDV, PRU, HCAT |
| Q1 2024 | 5 | $211.7M | SPY, VYM, HDV, PRU, HCAT |